tradingkey.logo
tradingkey.logo
Search

Incannex Healthcare Inc

IXHL
Add to Watchlist
3.970USD
+0.260+7.01%
Close 07/02, 13:00ETQuotes delayed by 15 min
54.32MMarket Cap
LossP/E TTM

TradingKey Stock Score of Incannex Healthcare Inc

Currency: USD Updated: 2026-07-02

Key Insights

Incannex Healthcare Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered undervalued, ranking 88 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.00.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Incannex Healthcare Inc's Score

Industry at a Glance

Industry Ranking
88 / 157
Overall Ranking
231 / 4565
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Incannex Healthcare Inc Highlights

StrengthsRisks
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalized anxiety disorder. Its lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnoea. IHL-42X has completed a Phase II clinical trial. PSX-001 is a synthetic psilocybin treatment for the treatment of generalized anxiety disorder. PSX-001 has completed a Phase II clinical trial. IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. IHL-675A is in a Phase II clinical development program.
Growing
The company is in a growing phase, with the latest annual income totaling USD 86.00K.
Overvalued
The company’s latest PE is -0.23, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 501.46K shares, increasing 33.10% quarter-over-quarter.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
18.000
Target Price
+385.18%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Incannex Healthcare Inc?

The TradingKey Stock Score provides a comprehensive assessment of Incannex Healthcare Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Incannex Healthcare Inc’s performance and outlook.

How do we generate the financial health score of Incannex Healthcare Inc?

To generate the financial health score of Incannex Healthcare Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Incannex Healthcare Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Incannex Healthcare Inc.

How do we generate the company valuation score of Incannex Healthcare Inc?

To generate the company valuation score of Incannex Healthcare Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Incannex Healthcare Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Incannex Healthcare Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Incannex Healthcare Inc.

How do we generate the earnings forecast score of Incannex Healthcare Inc?

To calculate the earnings forecast score of Incannex Healthcare Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Incannex Healthcare Inc’s future.

How do we generate the price momentum score of Incannex Healthcare Inc?

When generating the price momentum score for Incannex Healthcare Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Incannex Healthcare Inc’s prices. A higher score indicates a more stable short-term price trend for Incannex Healthcare Inc.

How do we generate the institutional confidence score of Incannex Healthcare Inc?

To generate the institutional confidence score of Incannex Healthcare Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Incannex Healthcare Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Incannex Healthcare Inc.

How do we generate the risk management score of Incannex Healthcare Inc?

To assess the risk management score of Incannex Healthcare Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Incannex Healthcare Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Incannex Healthcare Inc.